Paul Abernathy - May 4, 2023 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
Director
Signature
/s/ J. Paul Abernathy
Stock symbol
NHC
Transactions as of
May 4, 2023
Transactions value $
$0
Form type
4
Date filed
5/4/2023, 06:29 PM
Previous filing
Feb 27, 2023
Next filing
Aug 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NHC Shares of Common Stock 31.4K May 4, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock [2023 Grant] Award $0 +7.5K $0.00 7.5K May 4, 2023 Common Stock 7.5K $55.75 Direct F1
holding NHC Option to Purchase Common Stock 5.9K May 4, 2023 Common Stock 5.9K $77.92 Direct
holding NHC Option to Purchase Common Stock [2020 Grant] 7.5K May 4, 2023 Common Stock 7.5K $64.64 Direct
holding NHC Option to Purchase Common Stock [2021 Grant] 7.5K May 4, 2023 Common Stock 7.5K $71.64 Direct
holding NHC Option to Purchase Common Stock [2022 Grant] 7.5K May 4, 2023 Common Stock 7.5K $69.19 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursant to the 2020 Obmnibus Equity Incentive Plan on May 4, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).